Daily FNArena News - Australia

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest

Previous Stories

Boom Could Boom Again

Jan 22 2007

Success story Boom Logistics has been in the doldrums of late, but Intersuisse is tipping a re-rating ahead.


Investors Not Overly Excited About ConsMin Rumours

Jan 22 2007

Is former daytrader darling Consolidated Minerals about to fall into the hands of a Russian suitor? The West Australian thinks so. Thus far investors are lukewarm, at best.


Oz First Home Affordability Continues To Decline

Jan 22 2007

Housing prices may not be booming across Australia but the HIA and CBA note affordability continues to decline for first home buyers.


Short Term Outlook Clouded For Iluka

Jan 19 2007

Iluka has become a restructuring story. While long term value appears to be present, the short term outlook has many risks and uncertainties.


Worst May Be Over For Straits Resources

Jan 19 2007

Austock Securities sees value in Straits Resources as this year should see some better news and stronger earnings.


Now JP Morgan Downgrades Telstra

Jan 19 2007

Citigroup’s downgrade on Telstra yesterday has been followed today by JP Morgan, who also argues the stock is expensive and it is too early to price in success in the transformation process.


Are The Bulls Or Bears Right On Telstra?

Jan 18 2007

Telstra has received a number of upgrades to earnings and price targets in recent days, but Citigroup counters too much is being priced in and the stock is overvalued.


Babcock & Brown Power Attracting Maiden Buys

Jan 18 2007

Both Deutsche and Citigroup have initiated coverage on Babcock & Brown Power with Buy ratings, reflecting the combination of solid growth and an attractive yield.


NZ Interest Rates On Hold (?) But What About Australia?

Jan 18 2007

A CPI outcome at the lower end of expectations has brokers tipping New Zealand interest rates are on hold, while ongoing inflationary pressures in Australia suggest possible further hikes.


Shake Up Ahead For Australia’s Generic Drugs Sector

Jan 17 2007

If India’s Ranbaxy can increase its presence through the sale of Merck’s operations in Australia the news may not be so positive for Sigma and Genepharm Australasia, ABN Amro Morgans believes.



Analyse The Market From A Different Angle